Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT05124353
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 100 participants
- Registry
-
NCT05124353
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Unknown status
Technical summary
Registry record NCT05124353. Randomized; no masking; primary purpose treatment. Start 2021-04-27 (actual); primary completion 2023-04-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT
- Condition
- Stroke, Acute, Ischemic
- Intervention (Drug)
- Cerebrolysin
- Lead sponsor
- Pomeranian Medical University Szczecin
Record details
- Record id
cardio:ct-nct05124353- Content hash
a3d24420ac0b87a9937e9ee52124d96ec4c9051ade3758a590ab1f08f19d8dc7